Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friederike Mackensen

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Investigative Ophthalmology & Visual Science|March 20, 2012
A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 geneLars G Fritsche, Monika Fleckenstein, Britta S Fiebig, et al.
The British Journal of Ophthalmology|October 26, 2013
Use of intravitreal rituximab for treatment of vitreoretinal lymphomaKelly L Larkin, Ujwala S Saboo, Grant M Comer, et al.
Plos One|October 14, 2009
CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMDHendrik P N Scholl, Monika Fleckenstein, Lars G Fritsche, et al.
Arthritis and Rheumatism|January 11, 2005
A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory diseaseTammy M Martin, Ge Zhang, Jingchun Luo, et al.
American Journal of Ophthalmology|May 12, 2009
Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularizationAhmad M Mansour, J Fernando Arevalo, Focke Ziemssen, et al.
Rheumatology (Oxford, England)|November 23, 2014
Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomesCarlos D Rosé, Steven Pans, Ingele Casteels, et al.
Rheumatology (Oxford, England)|April 11, 2018
S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndromeLin Wang, Carlos D Rosé, Kevin P Foley, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 13, 2012
Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularizationAhmad M Mansour, J Fernando Arevalo, Christine Fardeau, et al.
American Journal of Ophthalmology|July 16, 2008
Intravitreal bevacizumab in inflammatory ocular neovascularizationAhmad M Mansour, Friederike Mackensen, J Fernando Arevalo, et al.
JAMA Ophthalmology|November 21, 2014
Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative studyAnjo Riemens, Jacoline Bromberg, Valerie Touitou, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Investigative Ophthalmology & Visual Science|March 20, 2012
A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 geneLars G Fritsche, Monika Fleckenstein, Britta S Fiebig, et al.
The British Journal of Ophthalmology|October 26, 2013
Use of intravitreal rituximab for treatment of vitreoretinal lymphomaKelly L Larkin, Ujwala S Saboo, Grant M Comer, et al.
Plos One|October 14, 2009
CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMDHendrik P N Scholl, Monika Fleckenstein, Lars G Fritsche, et al.
Arthritis and Rheumatism|January 11, 2005
A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory diseaseTammy M Martin, Ge Zhang, Jingchun Luo, et al.
American Journal of Ophthalmology|May 12, 2009
Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularizationAhmad M Mansour, J Fernando Arevalo, Focke Ziemssen, et al.
Rheumatology (Oxford, England)|November 23, 2014
Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomesCarlos D Rosé, Steven Pans, Ingele Casteels, et al.
Rheumatology (Oxford, England)|April 11, 2018
S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndromeLin Wang, Carlos D Rosé, Kevin P Foley, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 13, 2012
Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularizationAhmad M Mansour, J Fernando Arevalo, Christine Fardeau, et al.
American Journal of Ophthalmology|July 16, 2008
Intravitreal bevacizumab in inflammatory ocular neovascularizationAhmad M Mansour, Friederike Mackensen, J Fernando Arevalo, et al.
JAMA Ophthalmology|November 21, 2014
Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative studyAnjo Riemens, Jacoline Bromberg, Valerie Touitou, et al.
Pageof 6